ArticleInternational journal of women's health2026
Female Sexual Dysfunction and Irritable Bowel Syndrome: A Cross-Sectional Study in Jordanian Women.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Female sexual function can be influenced by many somatic and psychosocial factors. Many chronic diseases, such as irritable bowel syndrome (IBS), can induce long-term suffering leading to a negative effect on sexual function. The impact of IBS on women's sexual health is an underexplored area, particularly in Middle Eastern populations. The aim of this study is to compare the prevalence and domains of sexual dysfunction in Jordanian women with and without IBS. Patients and Methods: This is a cross-sectional study, conducted at two hospitals in Jordan, from February to August 2024. 504 women, aged 18 or more, agreed to participate in this study, including 279 diagnosed with IBS. Our questionnaire incorporated clinical and sociodemographic data, relevant items of the Rome IV criteria, and the validated Arabic version of the Female Sexual Function Index (FSFI). Results: Among 504 female participants (mean age 34.1 ± 10.7 years), 88.2% were found to have sexual dysfunction, defined as an FSFI score <26.55, in the IBS group, and 76% in the non-IBS group, with an odds ratio of 2.354 (p <0.001). IBS patients demonstrated significantly lower mean scores in most FSFI domains (desire, arousal, lubrication, orgasm, and satisfaction) and a lower total FSFI score (19.2 ± 9.9 vs 16.6 ± 10.2; p < 0.05 for all comparisons), while the pain domain did not differ significantly between the two groups. Logistic regression identified IBS as a statistically significant predictor of sexual dysfunction (p = 0.007). Conclusion: IBS is associated with a higher prevalence of female sexual dysfunction in Jordan, which was demonstrated by lower scores in most sexual function domains. Our findings emphasize the need to integrate sexual health assessment as a part of IBS care. Future studies should explore the causality and the mechanism of this relationship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.